Literature DB >> 29537075

Histopathologic subtype of hippocampal sclerosis and episodic memory performance before and after temporal lobectomy for epilepsy.

Shahram Saghafi1, Lisa Ferguson2,3, Olivia Hogue4, Jordan M Gales5, Richard Prayson5, Robyn M Busch2,3.   

Abstract

OBJECTIVE: The International League Against Epilepsy (ILAE) proposed a classification system for hippocampal sclerosis (HS) based on location and extent of hippocampal neuron loss. The literature debates the usefulness of this classification system when studying memory in people with temporal lobe epilepsy (TLE) and determining memory outcome after temporal lobe resection (TLR). This study further explores the relationship between HS ILAE subtypes and episodic memory performance in patients with TLE and examines memory outcomes after TLR.
METHODS: This retrospective study identified 213 patients with TLE who underwent TLR and had histopathological evidence of HS (HS ILAE type 1a = 92; type 1b = 103; type 2 = 18). Patients completed the Wechsler Memory Scale-3rd Edition prior to surgery, and 78% of patients had postoperative scores available. Linear regressions examined differences in preoperative memory scores as a function of pathology classification, controlling for potential confounders. Fisher's exact tests were used to compare pathology subtypes on the magnitude of preoperative memory impairment and the proportion of patients who experienced clinically meaningful postoperative memory decline.
RESULTS: Individuals with HS ILAE type 2 demonstrated better preoperative verbal memory performance than patients with HS ILAE type 1; however, individual data revealed verbal and visual episodic memory impairments in many patients with HS ILAE type 2. The base rate of postoperative memory decline was similar among all 3 pathology groups. SIGNIFICANCE: This is the largest reported overall sample and the largest subset of patients with HS ILAE type 2. Group data suggest that patients with HS ILAE type 2 perform better on preoperative memory measures, but individually there were no differences in the magnitude of memory impairment. Following surgery, there were no statistically significant differences between groups in the proportion of patients who declined. Future research should focus on quantitative measurements of hippocampal neuronal loss, and multicenter collaboration is encouraged. Wiley Periodicals, Inc.
© 2018 International League Against Epilepsy.

Entities:  

Keywords:  epilepsy surgery; hippocampus; neuropsychology; outcome; pathology; temporal lobe epilepsy

Mesh:

Year:  2018        PMID: 29537075     DOI: 10.1111/epi.14036

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

1.  Hippocampal Sclerosis and Memory: Continuing the Search for a Link in Temporal Lobe Epilepsy.

Authors:  William Barr
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

2.  Volumetric and shape analysis of the hippocampus in temporal lobe epilepsy with GAD65 antibodies compared with non-immune epilepsy.

Authors:  Estefanía Conde-Blanco; Saül Pascual-Diaz; Mar Carreño; Emma Muñoz-Moreno; José Carlos Pariente; Teresa Boget; Isabel Manzanares; Antonio Donaire; María Centeno; Francesc Graus; Nuria Bargalló
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

3.  Contributions of Hippocampal Volume to Cognition in Healthy Older Adults.

Authors:  Cheshire Hardcastle; Andrew O'Shea; Jessica N Kraft; Alejandro Albizu; Nicole D Evangelista; Hanna K Hausman; Emanuel M Boutzoukas; Emily J Van Etten; Pradyumna K Bharadwaj; Hyun Song; Samantha G Smith; Eric C Porges; Steven Dekosky; Georg A Hishaw; Samuel S Wu; Michael Marsiske; Ronald Cohen; Gene E Alexander; Adam J Woods
Journal:  Front Aging Neurosci       Date:  2020-11-05       Impact factor: 5.750

Review 4.  Quantitative Meta-Analyses: Lateralization of Memory Functions Before and After Surgery in Children with Temporal Lobe Epilepsy.

Authors:  Naomi Kahana Levy; Jonathan Segalovsky; Mony Benifla; Odelia Elkana
Journal:  Neuropsychol Rev       Date:  2021-03-06       Impact factor: 7.444

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.